Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?
作者信息
Stavropoulos Konstantinos, Imprialos Konstantinos P, Boutari Chrysoula, Athyros Vasilios G, Karagiannis Asterios I
机构信息
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
出版信息
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1073. doi: 10.1111/jch.12832. Epub 2016 Apr 21.
Abstract
摘要
相似文献
1
Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?卡格列净与高血压：它是所有高血压患者的最佳选择吗？
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1073. doi: 10.1111/jch.12832. Epub 2016 Apr 21.
2
[SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes].[卡格列净抑制钠-葡萄糖协同转运蛋白2：2型糖尿病治疗的新选择]
Dtsch Med Wochenschr. 2014 Feb;139 Suppl 2:S52-8. doi: 10.1055/s-0033-1359991. Epub 2014 Jan 30.
3
Cardiovascular safety of canagliflozin.卡格列净的心血管安全性。
Int J Cardiol. 2017 Nov 15;247:7. doi: 10.1016/j.ijcard.2017.06.128.
4
Reply to: Cardiovascular safety of canagliflozin.回复：卡格列净的心血管安全性。
Int J Cardiol. 2017 Nov 15;247:8. doi: 10.1016/j.ijcard.2017.07.075.
5
[Canagliflozin monotherapy: clinical study data in type 2 diabetes mellitus].卡格列净单药治疗：2型糖尿病的临床研究数据
Dtsch Med Wochenschr. 2014 Feb;139 Suppl 2:S59-64. doi: 10.1055/s-0033-1359992. Epub 2014 Jan 30.
6
Canagliflozin: a novel treatment option for type 2 diabetes.卡格列净：2型糖尿病的一种新型治疗选择。
Drug Des Devel Ther. 2013 Nov 22;7:1399-408. doi: 10.2147/DDDT.S48937. eCollection 2013.
7
Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study.在饮食和运动控制不佳的日本 2 型糖尿病患者中单用卡格列净的疗效和安全性：一项 24 周、随机、双盲、安慰剂对照的 III 期研究。
Expert Opin Pharmacother. 2014 Aug;15(11):1501-15. doi: 10.1517/14656566.2014.935764.
8
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.卡格列净治疗2型糖尿病合并慢性肾脏病患者52周的疗效与安全性
Diabetes Obes Metab. 2014 Oct;16(10):1016-27. doi: 10.1111/dom.12348. Epub 2014 Jul 22.
9
Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol.钠-葡萄糖协同转运蛋白2抑制剂卡格列净对血清1,5-脱水葡萄糖醇测定的影响。
J Diabetes. 2014 Jul;6(4):378-80. doi: 10.1111/1753-0407.12116. Epub 2014 Feb 25.
10
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.卡格列净单药治疗对饮食和运动控制不佳的2型糖尿病患者的长期疗效和安全性：来自52周CANTATA-M研究的结果
Curr Med Res Opin. 2014 Feb;30(2):163-75. doi: 10.1185/03007995.2013.850066. Epub 2013 Oct 28.
引用本文的文献
1
Response to Stavropoulos.对斯塔夫罗普洛斯的回应。
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1074-1075. doi: 10.1111/jch.12831. Epub 2016 Apr 21.
本文引用的文献
1
Reductions in Mean 24-Hour Ambulatory Blood Pressure After 6-Week Treatment With Canagliflozin in Patients With Type 2 Diabetes Mellitus and Hypertension.在2型糖尿病合并高血压患者中，使用卡格列净治疗6周后24小时动态平均血压的降低情况。
J Clin Hypertens (Greenwich). 2016 Jan;18(1):43-52. doi: 10.1111/jch.12747. Epub 2015 Dec 10.
2
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?钠-葡萄糖协同转运蛋白2抑制剂与血压降低：新型抗糖尿病药物类别的一项重要作用？
J Hypertens. 2015 Nov;33(11):2185-97. doi: 10.1097/HJH.0000000000000719.
3
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.体型和降压治疗对心血管事件发生率的影响：ACCOMPLISH 随机对照试验的亚组分析。
Lancet. 2013 Feb 16;381(9866):537-45. doi: 10.1016/S0140-6736(12)61343-9. Epub 2012 Dec 6.
4
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.黑人高血压的管理：国际高血压学会黑人共识声明的更新。
Hypertension. 2010 Nov;56(5):780-800. doi: 10.1161/HYPERTENSIONAHA.110.152892. Epub 2010 Oct 4.
5
Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis.在评估抗高血压治疗反应中诊室血压与动态血压的比较：一项荟萃分析。
J Hypertens. 2004 Mar;22(3):435-45. doi: 10.1097/00004872-200403000-00001.
Zotero 插件